LENZ — LENZ Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1815776 ·
Last close
$3.50
Market Cap
$109.97M
52W High
$32.13
52W Low
$2.80
ADV30
1,075,558
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 5,486,000 5,206,000 -34,172,000 -31,918,000 236,596,000 24,208,000 17,334,000
Mar 2026 1,901,000 825,000 -44,135,000 -41,488,000 272,535,000 24,772,000 26,043,000
Dec 2025 1,588,000 — -38,463,000 -35,896,000 305,876,000 25,179,000 21,537,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-127,631,000
Investing CF
$9,761,000
Financing CF
$123,024,000
CapEx
$-511,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.49
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-331,516,000
Inventory
$4,760,000
Receivables
$913,000
ST Investments
$166,750,000
EBIT TTM
$-149,688,000
Pretax Income TTM
$-140,266,000
Interest Exp TTM
—
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,359,000
EBITDA
$-149,251,008
Free Cash Flow
$-79,889,000
Enterprise Value
$-86,870,960
Total Cash
$197,303,008
Total Debt
$460,000
Shares Out
31,420,583
Trailing EPS
$-4.53
Book Value
$6.11
ROE
-72.7%
ROA
-44.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 19,088,000 -91,138,000 -82,127,000 305,876,000 21,537,000 284,339,000 -69,170,000
Dec 2024 0 -58,610,000 -49,769,000 215,304,000 11,220,000 204,084,000 -59,391,000
Dec 2023 0 -72,429,000 -69,968,000 70,376,000 163,088,000 -92,712,000 -60,380,000
Dec 2022 15,000,000 -10,483,000 -10,811,000 46,951,000 71,120,000 -24,169,000 -4,091,000

TTM Snapshot

Revenues TTM
$19,152,000
NetIncome TTM
$-126,002,000
OpCashFlow TTM
—
Assets (Latest)
$236,596,000
Forward EPS
$-1.47

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $3.21 · call volume: 4 · put volume: 346
Expected Move to 2027-03-19: ±$2.08 (64.80%) — implied range $1.13 – $5.29 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MOLN MOLECULAR PARTNERS AG $109.55M $2.86 —
CMPX Compass Therapeutics, Inc. $109.26M $0.61 —
CRDL Cardiol Therapeutics Inc. $113.53M $0.97 —
ENGN enGene Therapeutics Inc. $115.27M $1.72 —
ZURA Zura Bio Ltd $99.70M $1.03 —

News headlines (Yahoo Finance, 1h cache)

LENZ Therapeutics (LENZ) Stock Fair Value Moves Lower As Analysts Split On VIZZ
2026-11-04 07:10 · Yahoo
LENZ (LENZ) Q3 2026 Earnings Call Transcript
2026-11-02 19:17 · Yahoo
LENZ Therapeutics (LENZ) Stock Rallies As Q3 Results Expose Cash Burn
2026-10-30 10:11 · Yahoo
LENZ Therapeutics Q3 Earnings Call Highlights
2026-10-29 19:14 · Yahoo
LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Misses Revenue Estimates
2026-10-28 20:45 · Yahoo
LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
2026-10-28 20:30 · Yahoo
LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
2026-10-22 12:00 · Yahoo
LENZ Therapeutics (LENZ) Stock Fair Value Falls After Analysts Cut VIZZ Launch Expectations
2026-10-21 04:27 · Yahoo
LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts
2026-08-15 01:12 · Yahoo
LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ...
2026-08-12 05:02 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.